Bifidobacterium bifidum R0071

Bifidobacterium bifidum R0071 is a probiotic strain that produces beneficial metabolites like short-chain fatty acids and bacteriocins to modulate gut microbiota composition. It enhances immune function through interactions with gut-associated lymphoid tissue and may improve lactose digestion by producing beta-galactosidase enzyme.

Origin & History

Bifidobacterium bifidum R0071 is a probiotic strain that originates from the human gastrointestinal tract. It is known for its role in supporting digestive and immune health.

Historical & Cultural Context

Probiotics like Bifidobacterium bifidum have been used in traditional diets to support health and wellness for centuries.

Health Benefits

- Supports gut health by balancing microbiota, enhancing digestion and nutrient absorption. This balance helps reduce bloating and discomfort. - Enhances immune function by stimulating the production of antibodies. This can reduce the frequency of infections by up to 30%. - May improve lactose digestion by producing lactase enzyme. This can help those with lactose intolerance enjoy dairy products with fewer symptoms. - Reduces inflammation by modulating cytokine production. This may help alleviate symptoms of inflammatory bowel conditions. - Improves skin health by reducing systemic inflammation. This can lead to clearer, more radiant skin. - Aids in weight management by influencing the gut-brain axis. This may help regulate appetite and reduce cravings. - Supports mental health by producing neurotransmitters like serotonin. This can enhance mood and cognitive function.

How It Works

Bifidobacterium bifidum R0071 produces short-chain fatty acids (acetate, lactate) that lower intestinal pH and inhibit pathogenic bacteria growth. The strain synthesizes bacteriocins and adhesins that compete with harmful microorganisms for intestinal binding sites. It stimulates toll-like receptors on intestinal epithelial cells, activating NF-κB pathways that enhance mucosal immunity and antibody production.

Scientific Research

Bifidobacterium bifidum R0071 has been studied for its potential to improve gut health and enhance immune function, with promising results.

Clinical Summary

Clinical studies on Bifidobacterium bifidum strains typically involve 50-200 participants over 4-12 weeks. Research demonstrates significant reductions in gastrointestinal discomfort and 20-30% improvements in immune markers like secretory IgA levels. Most studies use dosages of 1-10 billion CFUs daily, though specific R0071 strain data is limited. Evidence quality ranges from moderate to high for digestive benefits, with emerging support for immune enhancement.

Nutritional Profile

- Contains live probiotic cultures. - Supports gut flora balance. - Provides beneficial bacteria for digestive health.

Preparation & Dosage

Typical dosage ranges from 1 to 10 billion CFUs per day. Consult a healthcare provider before use.

Synergy & Pairings

Lactobacillus acidophilus, Bifidobacterium longum, Galactooligosaccharides

Safety & Interactions

Bifidobacterium bifidum R0071 is generally well-tolerated with minimal side effects, though some users may experience mild bloating or gas during initial supplementation. It may interact with immunosuppressive medications by potentially enhancing immune responses. Individuals with severe immunocompromised conditions should consult healthcare providers before use. Safety during pregnancy and lactation has not been extensively studied, warranting medical supervision.